PT31 Reducing Health Inequality of Introducing SGLT2i Therapy in a Real-World Type 2 Diabetes Population With Diverse Patient Characteristics: A Distributional Cost-Effectiveness Analysis
Abstract
Authors
K.S. Chong C.T. Yang C.C. Wang H.T. Ou S. Kuo